26
Participants
Start Date
February 29, 2016
Primary Completion Date
November 30, 2016
Study Completion Date
November 30, 2016
GLPG1837 dose 1
two GLPG1837 tablets in the morning and two GLPG1837 tablets in the evening, for one week
GLPG1837 dose 2
two GLPG1837 tablets in the morning and two GLPG1837 tablets in the evening, for one week
GLPG1837 dose 3
two GLPG1837 tablets in the morning and two GLPG1837 tablets in the evening, for two weeks
Royal Adelaide Hospital, Adelaide
The Prince Charles Hospital, Chermside
Monash Medical Centre, Clayton
Sir Charles Gairdner Hospital, Nedlands
Mater Adult Hospital, South Brisbane
Fakultni nemocnice v Motole, Prague
Charité Universitätsmedizin Berlin, Berlin
Universitätsklinkikum Koeln, Cologne
Uniklinik Carl-Gustav-Carus, Dresden
Lungenheilkunde München-Pasing, München
Beamont Hospital, Dublin
St. Vincent's University Hospital, Dublin
Queen Elizabeth University Hospital, Glasgow
Liverpool Heart and Chest Hospital, Liverpool
Royal Brompton Hospital, London
The Medicines Evaluation Unit Ltd, Manchester
Lead Sponsor
Galapagos NV
INDUSTRY